News, Media & Publications

Help for Medicare Patients to Avoid ‘Donut Hole’

Posted in News on 7.5.2018

Dr. Jing Luo, in-house Physician Advisor at Alosa Health and faculty member in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital, recently spoke at the American Diabetes Association’s 78th Annual Scientific Sessions on the comparative effectiveness and cost-benefit impact of using analogue versus human insulin for managing type 2 diabetes. Significantly, the cost of insulin drives many Medicare patients …

Pitfalls of FDA’s Breakthrough Drug Program

Posted in News on 4.17.2018

While the FDA’s expedited review programs are often touted as a way of speedily getting life-saving or life-altering drugs into the hands of patients in need, some experts, among them Alosa Health founder Jerry Avorn, are skeptical about the FDA’s breakthrough drug therapy (BTD) program. Firstly, Avorn and colleagues note that the BTD program results in …

PACE Introduces Acute Pain Module

Posted in Updates on 4.9.2018

On the heels of Chronic Pain, Alosa Health has recently released an Acute Pain module through Pennsylvania’s PACE program. Acute pain is a frequent problem for older individuals and its prevalence has been shown to increase with age. Effective treatment of acute pain is important and reduces suffering, improves return to function, and importantly, may help prevent progression to …

Congenital Syphilis Program in Maryland Underway

Posted in Updates on 3.23.2018

After winning a bid to provide educational outreach services in the city of Baltimore, Alosa Health has partnered with Maryland Department of Health to develop educational training materials on the topic of congenital syphilis prevention and to deploy a field-based educational program. Rates of congenital syphilis has been on the rise in the state of Maryland in …

JAMA Study Challenges Efficacy of Opioids vs Non-addictive Alternatives

Posted in News on 3.21.2018

For some time now the medical community has sought guidance on responsible prescribing related to opioids. A large, randomized trial, recently published in JAMA, demonstrated that for patients with moderate-to-severe chronic back pain or hip or knee osteoarthritis pain, a non-opioid medication regimen produced as much pain relief and recovery of function as an opioid …

Psychology of Clinical Decision Making

Posted in News on 2.26.2018

In a Perspective piece published earlier this week in the New England Journal, Alosa Health Founder and Clinical Advisor Dr. Jerry Avorn discusses the science of decision-making. While the science of decision-making is a well-developed field, its application to the field of medicine has been slow. Dr. Avorn ascribes this slow uptake to medicine’s “ongoing assumption” that …

Contract Expansion Targets Opioid Epidemic in Pennsylvania

Posted in Updates on 1.11.2018

Alosa Health’s contract with Pennsylvania’s Pharmaceutical Assistance Contract for the Elderly (PACE) expands thanks to a $26.5 million federal grant awarded to the State of Pennsylvania to combat the opioid epidemic. The funding will allow Alosa to visit more PA physicians to provide educational outreach (academic detailing) to help them treat pain more effectively while avoiding …

Talking to Patients About Health Policy

Posted in News on 12.14.2017

Alosa Health founder and clinical consultant Dr. Jerry Avorn offered an opinion in the Journal of the Medical American Association’s (JAMA’s) essay feature on the topic of engaging patients in health policy talk. The question of whether clinicians should interact with their patients about health policy debates remains contentious; some argue that doing so is …

PACE Introduces Chronic Pain Module

Posted in Updates on 12.14.2017

Alosa Health has just released an updated Chronic Pain module through Pennsylvania’s PACE program. This educational program presents the most recent evidence for effectively treating pain in the elderly. The emphasis is on non-pharmacologic and non-opioid pharmacologic options, with the goal of minimizing or avoiding the use of opioid analgesics in this population. Academic detailers in Pennsylvania …

BALANCED INFORMATION FOR BETTER CARE